Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex

References

• Anand V, Kandarapu R, Garg S. (2001). Ion-exchange resins: carrying drug delivery forward. Drug Discov Today, 6:905–914.
   PubMed Web of Science ®Google Scholar
• Srikanth MV, Sunil SA, Rao NS, Uhamwangho MU, Murthy KVR. (2010). Ion-exchange resins as controlled drug delivery carriers. J Sci Res, 2:597–611.
   Google Scholar
• Sanghavi NM. (1988). Ion-exchange resins as matrices for controlled drug release. Indian Drugs, 26:27–32.
   Google Scholar
• Irwin WJ, Belaid KA, Alpar HO. (1987). Drug-delivery by ion-exchange. Part III: Interaction of ester prodrug of propranolol with cationic exchange resins. Drug Dev Ind Pharm, 13:2047–2066.
   Web of Science ®Google Scholar
• Jeong SH, Park K. (2008). Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm, 361:26–32.
   PubMed Web of Science ®Google Scholar
• Strickley RG. (2004). Solubilizing excipients in oral and injectable formulations. Pharm Res, 21:201–230.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev, 59:645–666.
   PubMed Web of Science ®Google Scholar
• Vyas A, Saraf S. (2008). Cyclodextrin based novel drug delivery systems. J Incl Phenom Macrocycl Chem, 62:23–42.
   Web of Science ®Google Scholar
• Higuchi T, Connors KA. (1965). Phase-solubility techniques. Adv Anal Chem Instrum, 4:117–212.
   Google Scholar
• Job P. (1928). Job’s plot analyses for the 2-CG and 3-CG complexes were consistent with 1:1 stoichiometry. Ann Chim, 9:113–134.
   Google Scholar
• Kunin R. (1963). Ion Exchange Resins. New York: John Wiley & Sons, Inc., 8–23.
   Google Scholar
• Liu R. (2008). Water-Insoluble Drug Formulation. London: CRC Press, 133–154.
   Google Scholar
• Higuchi T, Kristiansen H. (1970). Binding specificity between small organic solutes in aqueous solution: classification of some solutes into two groups according to binding tendencies. J Pharm Sci, 59:1601–1608.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Magnúsdóttir A, Másson M, Sigurjónsdóttir JF. (2002). Self-association and cyclodextrin solubilization of drugs. J Pharm Sci, 91:2307–2316.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. (2012). Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci, 101:3019–3032.
   PubMed Web of Science ®Google Scholar
• Luger P, Daneck K, Trummlitz WEG, Wagner K. (1996). Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci, 4:175–187.
   Web of Science ®Google Scholar
• Hilal SH, Karickhoff SW, Carreira LA. (1999). Estimation of microscopic, zwitterionic ionization constants, isoelectric point and molecular speciation of organic compounds. Talanta, 50:827–840.
   PubMed Web of Science ®Google Scholar
• Xiliang G, Yu Y, Guoyan Z, Guomei Z, Jianbin C, Shaomin S. (2003). Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives. Spectrochim Acta A Mol Biomol Spectrosc, 59:3379–3386.
   PubMed Web of Science ®Google Scholar
• Snor W, Liedl E, Weiss-Greiler P, Viernstein H, Wolschann P. (2009). Density functional calculations on meloxicam-beta-cyclodextrin inclusion complexes. Int J Pharm, 381:146–152.
   PubMed Web of Science ®Google Scholar
• Singh R, Bhart N, Madan J, Hiremath SN. (2010). Characterization of cyclodextrin inclusion complexes: A review. J Pharm Sci & Tech, 2:171–183.
   Google Scholar
• Obaidat AA, Khanfar RA, Khawam MN. (2009). The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling. J Incl Phenom Macrocycl Chem, 63:273–279.
   Web of Science ®Google Scholar
• Sinko PJ. (2011). Martin’s Physical Pharmacy and Pharmaceutical Sciences. London: Lippincott Williams & Wilkins, 197–222.
   Google Scholar
• Mura P, Bettinetti GP, Manderioli A, Faucci MT, Bramanti G, Sorrenti M. (1998). Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state. Int J Pharm, 166:189–203.
   Web of Science ®Google Scholar
• Mehta SK, Bhasin KK, Dham S. (2008). Energetically favorable interactions between diclofenac sodium and cyclodextrin molecules in aqueous media. J Colloid Interface Sci, 326:374–381.
   PubMed Web of Science ®Google Scholar
• Cabaleiro-Lago C, Nilsson M, Valente AJ, Bonini M, Söderman O. (2006). NMR diffusometry and conductometry study of the host-guest association between beta-cyclodextrin and dodecane 1,12-bis(trimethylammonium bromide). J Colloid Interface Sci, 300:782–787.
   PubMed Web of Science ®Google Scholar
• Ali MS, Rub MA, Khan F, Al-Lohedan HA, Din K. (2012). Interaction of amphiphilic drug amitriptyline hydrochloride with β-cyclodextrin as studied by conductometry, surface tensiometry and viscometry. J Mol Liq, 167:115–118.
   Web of Science ®Google Scholar
• Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S. (2004). Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS Pharm Sci Tech, 5:1–8.
   Google Scholar
• Singh I, Rehni AK, Kalra R, Joshi G, Kumar M, Aboul-Enein HY. (2007). Ion exchange resins: drug delivery and therapeutic applications. FABAD J Pharm Sci, 32:91–100.
   Google Scholar
• Guo X, Chang RK, Hussain MA. (2009). Ion-exchange resins as drug delivery carriers. J Pharm Sci, 98:3886–3902.
   PubMed Web of Science ®Google Scholar
• Akkaramongkolporn P, Kulvanich P, Pathipvanich M. (2006). Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine. Drug Dev Ind Pharm, 32:483–496.
   PubMed Web of Science ®Google Scholar
• Sriwongjanya M, Bodmeier R. (1997). Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm, 158:29–38.
   Web of Science ®Google Scholar